Adenoma, Islet Cell - 110 Studies Found
Terminated |
: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET : Islet Cell Tumor : 2011-06-14 :
|
Completed |
: Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors : Pancreatic Neuroendocrine Tumors : 2010-05-10 : Drug: Sunitinib Sunitinib capsule will be given orally at continuous daily dosing with a dose of 37.5 mg |
Recruiting |
: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders :
: 2009-01-27 : |
Terminated |
: Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors : Pancreatic Cancer : 2008-01-24 :
|
Active, not recruiting |
: RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors : Pancreatic Neuroendocrine Tumor : 2007-12-17 :
|
Terminated |
: A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors :
: 2007-01-29 :
|
Recruiting |
: Asymptomatic Small Pancreatic Endocrine Neoplasms. : Non Functioning Pancreatic Endocrine Tumor : 2017-03-06 :
|
Recruiting |
: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors) :
: 2017-02-02 :
|
Not yet recruiting |
: Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs :
|
Active, not recruiting |
: Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors :
: 2016-04-07 :
|